Transient congenital hypothyroidism due to transplacental passage of maternal TSH receptor blocking antibodies (Q86204): Difference between revisions

← Older edit

@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank

Latest revision as of 11:34, 15 August 2026

Transient congenital hypothyroidism can result from transplacental passage of maternal TSH-binding inhibitory antibodies. This occurs in mothers with autoimmune thyroiditis where immunoglobulin G (IgG) antithyroid antibodies are transmitted across the placenta and block TSH binding sites on the fetal thyroid. This form of congenital hypothyroidism generally resolves within the first 2 to 3 months of life.

Language	Label	Description	Also known as
default for all languages	ID_1032159701
English	Transient congenital hypothyroidism due to transplacental passage of maternal TSH receptor blocking antibodies	Transient congenital hypothyroidism can result from transplacental passage of maternal TSH-binding inhibitory antibodies. This occurs in mothers with autoimmune thyroiditis where immunoglobulin G (IgG) antithyroid antibodies are transmitted across the placenta and block TSH binding sites on the fetal thyroid. This form of congenital hypothyroidism generally resolves within the first 2 to 3 months of life.